- Home
- SEED vs PAVM Comparison
SEED vs PAVM Comparison
Compare SEED & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEED | PAVM |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 8.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SEED | PAVM |
|---|---|---|
| Price | $1.22 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 39.9K | ★ 275.9K |
| Earning Date | 02-09-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,910,081.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.74 | $0.27 |
| 52 Week High | $2.70 | $0.90 |
Technical Indicators
Market Signals| Indicator | SEED | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 38.37 | 38.18 |
| Support Level | $1.25 | $0.27 |
| Resistance Level | $1.33 | $0.31 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 1.81 | 10.76 |
Price Performance
Historical ComparisonAbout SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.